US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

BGNE

BeiGene (BGNE)

BeiGene Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BGNE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/16	01 : 05	Business Wire	BeiGene présentera à l’EHA2024 de nouvelles données sur l’étude SEQUOIA évaluant la bithérapie BRUKINSA® plus vénétoclax dans le traitement de première intention de patients atteints de LLC/PLL à haut risque	NASDAQ:BGNE	BeiGene Ltd
2024/06/15	22 : 42	Business Wire	EHA2024: BeiGene präsentiert neue Daten der SEQUOIA-Studie zu BRUKINSA® plus Venetoclax für die Erstlinienbehandlung von Hochrisiko-CLL/SLL	NASDAQ:BGNE	BeiGene Ltd
2024/06/14	19 : 00	Business Wire	BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024	NASDAQ:BGNE	BeiGene Ltd
2024/06/14	08 : 41	Business Wire	BeiGene and NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA® (Zanubrutinib) Partnership in the Middle East and Africa (MENA) Region	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	06 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	06 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	06 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	05 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	05 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	05 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	05 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	05 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/08	05 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BGNE	BeiGene Ltd
2024/06/06	06 : 23	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BGNE	BeiGene Ltd
2024/06/06	05 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGNE	BeiGene Ltd
2024/06/04	19 : 01	Business Wire	BeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:BGNE	BeiGene Ltd
2024/05/28	21 : 00	GlobeNewswire Inc.	BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study	NASDAQ:BGNE	BeiGene Ltd
2024/05/24	19 : 00	Business Wire	BRUKINSA® Data at ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLL	NASDAQ:BGNE	BeiGene Ltd
2024/05/16	07 : 10	Business Wire	EHA2024: BeiGene präsentiert neues Hämatologie-Portfolio und Pipeline-Daten	NASDAQ:BGNE	BeiGene Ltd
2024/05/16	06 : 50	Business Wire	BeiGene présente de nouvelles données de portefeuille et de pipeline d'hématologie à l'EHA2024	NASDAQ:BGNE	BeiGene Ltd
2024/05/15	05 : 01	Business Wire	BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024	NASDAQ:BGNE	BeiGene Ltd
2024/05/10	04 : 03	Business Wire	BeiGene meldet Finanzergebnisse für das erste Quartal 2024 und aktuelle Geschäftsentwicklungen	NASDAQ:BGNE	BeiGene Ltd
2024/05/09	22 : 38	Business Wire	ベイジーン、2024年第1四半期決算および事業に関する最新情報を発表	NASDAQ:BGNE	BeiGene Ltd
2024/05/09	10 : 02	Business Wire	BeiGene公布2024年第一季財務業績和最新業務情況	NASDAQ:BGNE	BeiGene Ltd
2024/05/09	08 : 03	Business Wire	BeiGene présente ses résultats financiers du premier trimestre 2024 et ses dernières nouvelles commerciales	NASDAQ:BGNE	BeiGene Ltd
2024/05/08	19 : 00	Business Wire	BeiGene Reports First Quarter 2024 Financial Results and Business Updates	NASDAQ:BGNE	BeiGene Ltd
2024/04/26	23 : 34	Business Wire	BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report	NASDAQ:BGNE	BeiGene Ltd
2024/04/25	20 : 11	Business Wire	Globaler Onkologie-Innovator BeiGene präsentiert auf der ASCO-Jahrestagung 2024 neue Daten aus dem gesamten Portfolio für Hämatologie und solide Tumore	NASDAQ:BGNE	BeiGene Ltd

Showing the most relevant articles for your search:NASDAQ:BGNE

1 2 3 4 5 6 7 8 9 10 次へ >>

Big Rock Partners Acquis...

OMX Copenhagen Oil, Gas ...

Ratch Group PCL (PK)

KBW Nasdaq Capital Marke...

NLBNPIT1XWL4 20261231 60

NLBNPIT1VQ15 20351219 15...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約